The deal gives J&J access to a pipeline of drugs designed to “hold and kill” tumors, led by a prostate cancer medicine that’s ...

Finasteride is used to treat androgenetic alopecia, also known as male pattern baldness. It works to regrow hair and prevent ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

Johnson & Johnson said it will purchase Halda Therapeutics, marking the first major buyout for a cancer drugmaker built ...

Johnson & Johnson said on Monday it would buy privately held Halda Therapeutics for $3.05 billion in cash, expanding the ...

Halda Therapeutics is developing oral assets for prostate and lung cancer. The deal comes after Johnson & Johnson set an ...

Johnson & Johnson has agreed to buy privately held cancer drugmaker Halda Therapeutics for $3bn in the latest hotly contested ...

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

Lab testing giant ALS has surfed a boom in minerals testing to produce a strong interim result, despite a drug assay downturn ...

Analyst highlights three biotech stocks with major cancer-therapy catalysts and novel drug platforms, including key data ...

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy US biotech Halda Therapeutics and ...